Novo Taps OpenAI to Speed Development of New Obesity Drugs

Published on April 14, 2026

Novo Nordisk A/S will integrate OpenAI’s artificial intelligence across the company to accelerate drug development.

Continue reading on website
Other news

Treasuries Steady as Traders Assess War’s Inflation Risks

April 14, 2026
Treasuries traded steadily after a reading of US wholesale prices last month rose less than anticipated, affirming wagers that the Federal Reserve will cut interest rates at least once this year even as the broader inflationary outlook remains murky amid the war in Iran.

Multiple Jobholders Account for 5.2% of Workers in March 2026

April 14, 2026
Multiple jobholders accounted for 5.2% of civilian employment in March.